Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
SNSE
SNSE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SNSE News
Biotech Stocks Surge: Coherus Up 9.09% in After-Hours Trading
Jan 23 2026
NASDAQ.COM
What Caused Sensei Biotherapeutics (SNSE) Stock to Surge Nearly 63% in After-Hours Trading?
Dec 05 2025
Benzinga
Healthcare and Biotech Stocks Surge in After-Hours Trading: Sensei, Praxis, Cooper, Vanda, Cue, ResMed
Dec 05 2025
NASDAQ.COM
Sensei Biotherapeutics Launches Strategic Review Aimed at Enhancing Shareholder Value
Oct 30 2025
Newsfilter
Post-Market Jump: Turn Therapeutics Soars 134% Following Nasdaq Debut; Biotech Stocks Rise
Oct 09 2025
NASDAQ.COM
HC Wainwright & Co. Maintains Buy on Sensei Biotherapeutics, Raises Price Target to $30
Aug 05 2025
Benzinga
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Aug 05 2025
Newsfilter
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
Jul 30 2025
Newsfilter
Upcoming Stock Splits This Week (June 16 to June 20) – Stay Invested
Jun 15 2025
TipRanks
Sensei Biotherapeutics to execute 1-for-20 reverse stock split
Jun 13 2025
SeekingAlpha
Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress
May 06 2025
Newsfilter
Sensei Biotherapeutics (SNSE) Gets a Buy from Oppenheimer
Mar 30 2025
Business Insider
Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors
Mar 28 2025
Benzinga
Oppenheimer Maintains Outperform on Sensei Biotherapeutics, Raises Price Target to $4
Mar 28 2025
Benzinga
Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress
Mar 28 2025
Newsfilter
Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Mar 28 2025
Benzinga
Show More News
